Delivery Order SPE2DR25D1110-SPE2DR26F12UD
Award Date 10/20/25
Potential Completion Date 10/21/25
Potential Value $3.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,227.66 delivery order to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (unit dose 10s) on July 23, 2025, with completion targeted for July 24, 2025. This competitively awarded, firm fixed-price contract reflects a routine pharmaceutical procurement through the agency's medical supply chain. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $3,692.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (10 unit dose tablets) on August 26, 2025, with ultimate completion by August 27, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from the vendor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $9,481.53 for UBRELVY 100 mg tablets (16 unit dose packages) on August 22, 2025, with completion targeted for August 25, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $2,164.44 to AmerisourceBergen Drug Corp for the supply of UBRELVY 100 mg tablets (10-count unit dose packaging) on September 19, 2025, with completion expected by September 22, 2025. This competitively awarded, non-set-aside firm fixed price delivery order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of UBRELVY 100 MG tablets in unit dose packaging (10 tablets per unit). This competitively awarded, firm fixed-price delivery order has a ceiling value of $6,583.77 and an ultimate completion date of September 17, 2025. The contract is issued without a set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of UBRELVY 100 mg tablets in unit dose packages of 10 units, with a ceiling value of $11,874.35. This is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and carries no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of UBRELVY 100 mg tablet unit dose packages (10 count). This competitively awarded, non-set-aside contract carries a ceiling value of $3,712.21 with a firm fixed price structure and an ultimate completion date of August 27, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of UBRELVY 100 mg tablets in unit dose packaging (16 count). The contract, valued at $12,694.80, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award authority. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor...
- The Defense Logistics Agency (DLA) awarded a $3,430.55 delivery order to AmerisourceBergen Drug Corp for UBRELVY 50 mg tablets (10 units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This is a firm fixed-price, non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and...
- The Defense Logistics Agency awarded a delivery order valued at $6,244.42 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablet unit dose packages (16 count) on September 8, 2025, with completion expected by September 9, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of the company's pharmaceutical supply support to federal military and healthcare systems. The product will be delivered to AmerisourceBergen's corporate office location in...